Tower Research Capital LLC TRC boosted its position in Morgan Stanley (NYSE:MS) by 90.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,324 shares of the financial services provider’s stock after buying an additional 4,417 shares during the period. Tower Research Capital LLC TRC’s holdings in Morgan Stanley were worth $489,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of the stock. Robeco Institutional Asset Management B.V. increased its holdings in Morgan Stanley by 1.1% during the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 350,539 shares of the financial services provider’s stock worth $16,885,000 after purchasing an additional 3,862 shares in the last quarter. Honkamp Krueger Financial Services Inc. bought a new stake in Morgan Stanley during the 3rd quarter worth approximately $222,000. Douglas Lane & Associates LLC increased its holdings in Morgan Stanley by 24.2% during the 3rd quarter. Douglas Lane & Associates LLC now owns 668,397 shares of the financial services provider’s stock worth $32,197,000 after purchasing an additional 130,129 shares in the last quarter. Alpha Cubed Investments LLC bought a new stake in Morgan Stanley during the 3rd quarter worth approximately $235,000. Finally, CAPROCK Group Inc. bought a new stake in Morgan Stanley during the 3rd quarter worth approximately $220,000. 86.32% of the stock is owned by institutional investors and hedge funds.
MS has been the subject of a number of recent research reports. Zacks Investment Research lowered Morgan Stanley from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. JPMorgan Chase & Co. reissued a “buy” rating on shares of Morgan Stanley in a report on Monday, November 20th. Keefe, Bruyette & Woods raised Morgan Stanley from a “market perform” rating to an “outperform” rating and set a $59.00 price objective for the company in a report on Tuesday, December 12th. Wells Fargo & Co set a $55.00 price objective on Morgan Stanley and gave the stock a “hold” rating in a report on Wednesday, December 20th. Finally, Barclays boosted their price objective on Morgan Stanley from $52.00 to $62.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 2nd. One analyst has rated the stock with a sell rating, seven have given a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the stock. Morgan Stanley currently has an average rating of “Buy” and an average price target of $54.07.
In related news, Director Alistair Darling sold 3,850 shares of the company’s stock in a transaction that occurred on Friday, November 24th. The stock was sold at an average price of $49.29, for a total value of $189,766.50. Following the transaction, the director now owns 14,218 shares in the company, valued at $700,805.22. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Keishi Hotsuki sold 25,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $50.00, for a total value of $1,250,000.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 268,104 shares of company stock worth $14,524,785. 0.35% of the stock is owned by company insiders.
Morgan Stanley (MS) opened at $55.10 on Thursday. Morgan Stanley has a 12 month low of $40.06 and a 12 month high of $58.05. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 2.68. The company has a market capitalization of $98,447.28, a P/E ratio of 17.83, a P/E/G ratio of 0.95 and a beta of 1.54.
Morgan Stanley (NYSE:MS) last posted its quarterly earnings data on Thursday, January 18th. The financial services provider reported $0.84 EPS for the quarter, beating the consensus estimate of $0.77 by $0.07. Morgan Stanley had a return on equity of 10.03% and a net margin of 14.10%. The business had revenue of $9.50 billion for the quarter, compared to the consensus estimate of $9.25 billion. During the same quarter in the prior year, the business earned $0.81 earnings per share. Morgan Stanley’s revenue for the quarter was up 5.3% on a year-over-year basis. equities analysts expect that Morgan Stanley will post 4.51 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Wednesday, January 31st were paid a $0.25 dividend. The ex-dividend date of this dividend was Tuesday, January 30th. This represents a $1.00 annualized dividend and a yield of 1.81%. Morgan Stanley’s payout ratio is 32.36%.
ILLEGAL ACTIVITY NOTICE: “Morgan Stanley (MS) Shares Bought by Tower Research Capital LLC TRC” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/22/morgan-stanley-ms-shares-bought-by-tower-research-capital-llc-trc.html.
Morgan Stanley Profile
Morgan Stanley is a financial holding company. The Company’s segments include Institutional Securities, Wealth Management and Investment Management. The Company’s Institutional Securities business segment provides investment banking, sales and trading, and other services to corporations, governments, financial institutions and high-to-ultra high net worth clients.
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.